Antibacterial efficacy of silver nanoparticles against metallo-β-lactamase (blaNDM, blaVIM, blaOXA) producing clinically isolated Pseudomonas aeruginosa

Carbapenem resistance in Pseudomonas aeruginosa is a major concern in the public health sector, primarily in developing countries such as Pakistan. Therefore, novel approaches such as Silver nanoparticles (AgNPs) can be used to address emerging concerns. Clinical isolates (n=200) were reconfirmed us...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pakistan journal of pharmaceutical sciences 2021-01, Vol.34 (1(Supplementary)), p.237-243
Hauptverfasser:	Qureshi, Rabia, Qamar, Muhammad Usman, Shafique, Muhammad, Muzammil, Saima, Rasool, Muhammad Hidayat, Ahmad, Ijaz, Ejaz, Hasan
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology Bacterial Proteins - metabolism beta-Lactam Resistance beta-Lactamases - metabolism Ciprofloxacin - pharmacology Drug Resistance, Bacterial Humans Levofloxacin - pharmacology Metal Nanoparticles Microbial Sensitivity Tests Microbial Viability - drug effects Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - isolation & purification Pseudomonas aeruginosa - metabolism Pseudomonas aeruginosa - physiology Pseudomonas Infections - microbiology Silver - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!